Related Experiment Video

Updated: May 18, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Implications of geographical variation on clinical outcomes of cardiovascular trials

Robert J Mentz1, Juan-Carlos Kaski, Gheorghe-Andrei Dan

  • 1Duke University Medical Center, Durham, NC, USA. robert.mentz@duke.edu

American Heart Journal
|September 18, 2012
PubMed

Insights

Global cardiovascular clinical trials face challenges due to regional variations in patient populations and practices, potentially impacting results and generalizability. Standardizing trial result presentation is crucial for reliable global cardiovascular research.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Global Health

Background:

  • Cardiovascular clinical trials are increasingly globalized to improve efficiency and regulatory compliance.
  • Globalization introduces challenges such as regional variations in patient characteristics, medical practices, and health policies.
  • Concerns exist regarding ethical conduct and quality oversight in regions with limited trial infrastructure.

Purpose of the Study:

  • To review geographical differences in cardiovascular clinical trials.
  • To explore explanations for these observed geographical variations.
  • To propose methods for standardizing the presentation of cardiovascular trial results.

Main Methods:

  • Review of geographical differences in cardiovascular trials focusing on heart failure, acute coronary syndromes, hypertension, and atrial fibrillation.
  • Analysis of potential explanations for regional disparities.
  • Discussion on standardizing trial result reporting.

Main Results:

  • Significant geographical differences exist in cardiovascular trials across various conditions.
  • Variations are influenced by patient demographics, local medical practices, and health policies.
  • Potential for ethical and quality issues in less experienced regions necessitates careful consideration.

Conclusions:

  • Globalization of cardiovascular trials presents both opportunities and significant challenges.
  • Addressing regional differences and standardizing result presentation are vital for the integrity and generalizability of global cardiovascular research.
  • Further efforts are needed to ensure ethical conduct and quality oversight in international clinical trials.

More Related Videos

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System02:47

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is: